Effectiveness of a Case Management Model for Patients With Hypertension and Type II Diabetes in Chile
NCT ID: NCT02762695
Last Updated: 2017-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
616 participants
INTERVENTIONAL
2016-05-04
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case Management
Case Management
A model of health care for chronic patients, based on Case Management and guided by a nurse which targets the patient´s risk.
The core elements of this strategy are: a. processes to identify specific population and their risk; b. evidence-based practice guidelines according to risk (higher risk, more interventions and monitoring by a nurse, lower risk, higher emphasis on self-care); c. Practice models based on collaboration between health team members leaded by a nurse; d. self-management education for patients; e. monitoring patients face to face or by telephone to ensure to follow the care program (blood test, medical consultation, for example); e. measurement of process and outcomes.
Control
Usual Care at Primary Health Care
Usual Care
Usual Care at Primary Health Care Center
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Case Management
A model of health care for chronic patients, based on Case Management and guided by a nurse which targets the patient´s risk.
The core elements of this strategy are: a. processes to identify specific population and their risk; b. evidence-based practice guidelines according to risk (higher risk, more interventions and monitoring by a nurse, lower risk, higher emphasis on self-care); c. Practice models based on collaboration between health team members leaded by a nurse; d. self-management education for patients; e. monitoring patients face to face or by telephone to ensure to follow the care program (blood test, medical consultation, for example); e. measurement of process and outcomes.
Usual Care
Usual Care at Primary Health Care Center
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe hearing loss.
* Diagnosed with cancer
* Stage 4 or 5 of chronic kidney disease
18 Years
82 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Comisión Nacional de Investigación Científica y Tecnológica
OTHER_GOV
Pontificia Universidad Catolica de Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fernando Poblete Arrué
MD, MPH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando C Poblete, Master
Role: STUDY_CHAIR
Pontificia Universidad Catolica de Chile
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CESFAM La Faena
Peñalolén, RM, Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID15I10277
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
15-277
Identifier Type: -
Identifier Source: org_study_id